In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones-Reference-Cited by-同舟云学术

In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones

Published:2000-04 Issue:2 Volume:861 Page:305-315
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Cohen Victor I,Jin Biyun,McRee R.Carter,Boulay Sheila F,Cohen Emil I,Sood Virendar K,Zeeberg Barry R,Reba Richard C

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference49 articles.

1. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease;Araujo;J. Neurochem.,1988

2. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases;Aubert;J. Neurochem.,1992

3. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain;Aubert;Eur. J. Pharmacol.,1992

4. Comparison of the in vivo rat brain regional pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB binding to the muscarinic acetylcholine receptor in relationship to the regional subtype composition;Boulay;Receptor,1996

5. Autoradiographic evidence that 3-quinuclidinyl 4-fluorobenzilate (FQNB) displays in vivo selectivity for the m2 subtype;Boulay;NeuroImage,1996

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional characterization of muscarinic autoreceptors in rat and human neocortex;Journal of Neurochemistry;2009-08

2. Chapter 1 Cholinergic components of frontal lobe function and dysfunction;Neuropsychology and Behavioral Neurology;2008

3. The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release;European Journal of Pharmacology;2005-01

4. Structure−Activity Relationships of Dimethindene Derivatives as New M2-Selective Muscarinic Receptor Antagonists;Journal of Medicinal Chemistry;2003-01-30

5. Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies;Progress in Neurobiology;2002-10